These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 25589003)

  • 1. Sporadic hemangioblastomas are characterized by cryptic VHL inactivation.
    Shankar GM; Taylor-Weiner A; Lelic N; Jones RT; Kim JC; Francis JM; Abedalthagafi M; Borges LF; Coumans JV; Curry WT; Nahed BV; Shin JH; Paek SH; Park SH; Stewart C; Lawrence MS; Cibulskis K; Thorner AR; Van Hummelen P; Stemmer-Rachamimov AO; Batchelor TT; Carter SL; Hoang MP; Santagata S; Louis DN; Barker FG; Meyerson M; Getz G; Brastianos PK; Cahill DP
    Acta Neuropathol Commun; 2014 Dec; 2():167. PubMed ID: 25589003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reconsideration of biallelic inactivation of the VHL tumour suppressor gene in hemangioblastomas of the central nervous system.
    Gläsker S; Bender BU; Apel TW; van Velthoven V; Mulligan LM; Zentner J; Neumann HP
    J Neurol Neurosurg Psychiatry; 2001 May; 70(5):644-8. PubMed ID: 11309459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular genetic analysis of the von Hippel-Lindau disease tumor suppressor gene in familial and sporadic cerebellar hemangioblastomas.
    Tse JY; Wong JH; Lo KW; Poon WS; Huang DP; Ng HK
    Am J Clin Pathol; 1997 Apr; 107(4):459-66. PubMed ID: 9124215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extraneuraxial hemangioblastoma: A clinicopathologic study of 10 cases with molecular analysis of the VHL gene.
    Muscarella LA; Bisceglia M; Galliani CA; Zidar N; Ben-Dor DJ; Pasquinelli G; la Torre A; Sparaneo A; Fanburg-Smith JC; Lamovec J; Michal M; Bacchi CE
    Pathol Res Pract; 2018 Aug; 214(8):1156-1165. PubMed ID: 29941223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity and somatic mutations of the VHL tumor suppressor gene in sporadic cerebellar hemangioblastomas.
    Lee JY; Dong SM; Park WS; Yoo NJ; Kim CS; Jang JJ; Chi JG; Zbar B; Lubensky IA; Linehan WM; Vortmeyer AO; Zhuang Z
    Cancer Res; 1998 Feb; 58(3):504-8. PubMed ID: 9458097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of von hippel-lindau mutations with comparative genomic hybridization in sporadic and hereditary hemangioblastomas: possible genetic heterogeneity.
    Gijtenbeek JM; Jacobs B; Sprenger SH; Eleveld MJ; van Kessel AG; Kros JM; Sciot R; van Calenbergh F; Wesseling P; Jeuken JW
    J Neurosurg; 2002 Oct; 97(4):977-82. PubMed ID: 12405390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Difference in CXCR4 expression between sporadic and VHL-related hemangioblastoma.
    Kruizinga RC; van Marion DM; den Dunnen WF; de Groot JC; Hoving EW; Oosting SF; Timmer-Bosscha H; Derks RP; Cornelissen C; van der Luijt RB; Links TP; de Vries EG; Walenkamp AM
    Fam Cancer; 2016 Oct; 15(4):607-16. PubMed ID: 26920352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas.
    Kanno H; Kondo K; Ito S; Yamamoto I; Fujii S; Torigoe S; Sakai N; Hosaka M; Shuin T; Yao M
    Cancer Res; 1994 Sep; 54(18):4845-7. PubMed ID: 8069849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case report: a synonymous VHL mutation (c.414A > G, p.Pro138Pro) causes pathogenic familial hemangioblastoma through dysregulated splicing.
    Liu F; Calhoun B; Alam MS; Sun M; Wang X; Zhang C; Haldar K; Lu X
    BMC Med Genet; 2020 Feb; 21(1):42. PubMed ID: 32106822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity at 6q is frequent and concurrent with 3p loss in sporadic and familial capillary hemangioblastomas.
    Lemeta S; Pylkkänen L; Sainio M; Niemelä M; Saarikoski S; Husgafvel-Pursiainen K; Böhling T
    J Neuropathol Exp Neurol; 2004 Oct; 63(10):1072-9. PubMed ID: 15535134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intronic mutation of the VHL gene associated with central nervous system hemangioblastomas in two Chinese families with Von Hippel-Lindau disease: case report.
    Liu Z; Zhou J; Li L; Yi Z; Lu R; Li C; Gong K
    BMC Med Genet; 2020 Oct; 21(1):191. PubMed ID: 33004005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristic chromosomal aberrations in sporadic cerebellar hemangioblastomas revealed by comparative genomic hybridization.
    Sprenger SH; Gijtenbeek JM; Wesseling P; Sciot R; van Calenbergh F; Lammens M; Jeuken JW
    J Neurooncol; 2001 May; 52(3):241-7. PubMed ID: 11519854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An 11-bp duplication in the promoter region of the VHL gene in a patient with cerebellar hemangioblastoma and renal oncocytoma.
    Muscarella LA; Barbano R; Augello B; Formica V; Micale L; Zelante L; D'Agruma L; Merla G
    J Hum Genet; 2007; 52(6):485-491. PubMed ID: 17437055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in genetic and epigenetic alterations between von Hippel-Lindau disease-related and sporadic hemangioblastomas of the central nervous system.
    Takayanagi S; Mukasa A; Tanaka S; Nomura M; Omata M; Yanagisawa S; Yamamoto S; Ichimura K; Nakatomi H; Ueki K; Aburatani H; Saito N
    Neuro Oncol; 2017 Sep; 19(9):1228-1236. PubMed ID: 28379443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A vitronectin M381T polymorphism increases risk of hemangioblastoma in patients with VHL gene defect.
    Huang JS; Lin CM; Cheng YC; Hung KL; Chien CC; Chen SK; Chang CJ; Chen CW; Huang CJ
    J Mol Med (Berl); 2009 Jun; 87(6):613-22. PubMed ID: 19288063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and molecular analysis of disseminated hemangioblastomatosis of the central nervous system in patients without von Hippel-Lindau disease. Report of four cases.
    Weil RJ; Vortmeyer AO; Zhuang Z; Pack SD; Theodore N; Erickson RK; Oldfield EH
    J Neurosurg; 2002 Apr; 96(4):775-87. PubMed ID: 11990821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Putative control of angiogenesis in hemangioblastomas by the von Hippel-Lindau tumor suppressor gene.
    Stratmann R; Krieg M; Haas R; Plate KH
    J Neuropathol Exp Neurol; 1997 Nov; 56(11):1242-52. PubMed ID: 9370235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. von Hippel-Lindau gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with von Hippel-Lindau disease.
    Vortmeyer AO; Gnarra JR; Emmert-Buck MR; Katz D; Linehan WM; Oldfield EH; Zhuang Z
    Hum Pathol; 1997 May; 28(5):540-3. PubMed ID: 9158701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular pathology and CXCR4 expression in surgically excised retinal hemangioblastomas associated with von Hippel-Lindau disease.
    Liang X; Shen D; Huang Y; Yin C; Bojanowski CM; Zhuang Z; Chan CC
    Ophthalmology; 2007 Jan; 114(1):147-56. PubMed ID: 17070589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathology, genetics and cell biology of hemangioblastomas.
    Wizigmann-Voos S; Plate KH
    Histol Histopathol; 1996 Oct; 11(4):1049-61. PubMed ID: 8930647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.